MetaVia Inc. Faces Delisting Concerns
Ticker: MTVA · Form: 8-K · Filed: May 30, 2025 · CIK: 1638287
| Field | Detail |
|---|---|
| Company | Metavia INC. (MTVA) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-actions
TL;DR
MetaVia's in trouble, might get delisted.
AI Summary
MetaVia Inc. filed an 8-K on May 30, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company, formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., is based in Cambridge, MA.
Why It Matters
This filing indicates potential issues with MetaVia Inc.'s continued listing on an exchange, which could significantly impact its stock value and trading liquidity.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a severe risk to investors.
Key Players & Entities
- MetaVia Inc. (company) — Registrant
- May 29, 2025 (date) — Earliest event reported
- May 30, 2025 (date) — Date of report
- NeuroBo Pharmaceuticals, Inc. (company) — Former company name
- Gemphire Therapeutics Inc. (company) — Former company name
- Cambridge, Massachusetts (location) — Principal executive offices
FAQ
What specific listing rule or standard has MetaVia Inc. failed to satisfy?
The filing does not specify the exact rule or standard that MetaVia Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy one has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 29, 2025.
What is MetaVia Inc.'s principal executive office address?
MetaVia Inc.'s principal executive office is located at 545 Concord Avenue, Suite 210, Cambridge, Massachusetts 02138.
What were MetaVia Inc.'s previous company names?
MetaVia Inc. was formerly known as NeuroBo Pharmaceuticals, Inc. and prior to that, Gemphire Therapeutics Inc.
What is the filing date of this 8-K report?
This 8-K report was filed on May 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding MetaVia Inc. (MTVA).